Noncausal effects between tea intake and migraine risk: a Mendelian randomization study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 08 2023
09 08 2023
Historique:
received:
09
01
2023
accepted:
06
08
2023
medline:
11
8
2023
pubmed:
10
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
Observational studies have yielded conflicting results regarding the relationship between tea intake and migraine risk. Residual confounders and potential reverse causality are unavoidable in traditional observational studies. To provide evidence for establishing viable disease screening and prevention strategies, a Mendelian randomization study (MR) was conducted to determine the causal inference between tea intake and migraine. We obtained 28 single-nucleotide polymorphisms (SNPs) for any migraine (AM), 25 SNPs for migraine with aura (MA), and 27 SNPs for migraine without aura (MO) associated with tea intake derived from a large genome-wide association study (GWAS) of the UK Biobank (UKBB) (containing 447,485 samples). The largest migraine GWAS performed by the International Headache Genetics Consortium (IHGC), including 29,209 cases and 172,931 controls, provided data on migraines and their subtypes (MA and MO). We used the method of inverse variance weighting (IVW) with fixed effects as the first-string MR selection. Sensitivity analysis and MR-pleiotropy residual sum and outlier (MR-PRESSO) method further assessed the robustness of the findings. Based on the conclusion of IVW in the fixed effects model, we found that tea intake had no causal relationship with AM risk (odds ratio (OR), 0.94; 95% confidence interval (CI), 0.70-1.25; P = 0.65), MA risk (OR, 0.93; 95% CI, 0.51-1.72; P = 0.83), or MO risk (OR, 0.90; 95% CI, 0.52-1.54; P = 0.69). Sensitivity analyses and MR-PRESSO showed no directional pleiotropy or heterogeneity. Our two-sample MR investigation found no causality between tea intake and migraine risk in European populations, implying that attempts to change tea drinking habits may not lead to a reduced risk of migraine.
Identifiants
pubmed: 37558735
doi: 10.1038/s41598-023-40171-z
pii: 10.1038/s41598-023-40171-z
pmc: PMC10412590
doi:
Substances chimiques
Tea
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12898Informations de copyright
© 2023. Springer Nature Limited.
Références
Front Genet. 2022 Mar 29;13:835917
pubmed: 35422845
Br J Anaesth. 1994 Mar;72(3):295-7
pubmed: 8130047
Bioinformatics. 2019 Nov 1;35(22):4851-4853
pubmed: 31233103
Cephalalgia. 2003 Jun;23(5):332-5
pubmed: 12780761
Cephalalgia. 2005 Oct;25(10):776-87
pubmed: 16162254
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Cephalalgia. 2019 Dec;39(14):1838-1846
pubmed: 31307206
Int J Epidemiol. 2015 Apr;44(2):496-511
pubmed: 25953784
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Nat Genet. 2016 Aug;48(8):856-66
pubmed: 27322543
Am Fam Physician. 2013 Jan 1;87(1):11
pubmed: 23317021
Hum Mol Genet. 2017 Feb 15;26(4):820-828
pubmed: 28025330
Eur J Epidemiol. 2017 May;32(5):377-389
pubmed: 28527048
Headache. 2004 Jan;44(1):8-19
pubmed: 14979878
Pharmgenomics Pers Med. 2021 Aug 13;14:971-976
pubmed: 34413668
JAMA. 2021 Oct 26;326(16):1614-1621
pubmed: 34698778
Int J Epidemiol. 2013 Oct;42(5):1497-501
pubmed: 24159078
J Headache Pain. 2009 Jun;10(3):153-9
pubmed: 19308315
Front Endocrinol (Lausanne). 2021 Nov 09;12:763538
pubmed: 34858335
Int J Epidemiol. 2011 Jun;40(3):755-64
pubmed: 21414999
Nat Genet. 2018 May;50(5):693-698
pubmed: 29686387
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Front Nutr. 2022 Sep 26;9:938201
pubmed: 36225867
Front Genet. 2022 Jan 25;13:792313
pubmed: 35145549
Maturitas. 2013 Nov;76(3):243-6
pubmed: 23759429
Addiction. 2022 May;117(5):1382-1391
pubmed: 34859517